首页> 外文OA文献 >302 A phase IB study of indirect immunization with Oregovomab and TLR3 stimulation with hiltonol® (H) in patients with recurrent platinum resistant ovarian cancer (PROC)

【2h】

302 A phase IB study of indirect immunization with Oregovomab and TLR3 stimulation with hiltonol® (H) in patients with recurrent platinum resistant ovarian cancer (PROC)

机译：302 A相IB研究与奥克托莫氏瘤和TLR3刺激与Hiltonol®（h）患者复发性铂抗性卵巢癌（PROC）的间接免疫研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
R Holloway; S Temkin; S Gordon; C Nicodemus; M Madiyalakan; W McGuire;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients (vol 69, pg 383, 2020) [J] . Battaglia Alessandra, Buzzonetti Alexia, Fossati Marco, Cancer immunology, immunotherapy : . 2020,第7期

机译：在卵巢癌患者中使用预定组合治疗的随机相位II研究中间接抗体免疫接种的平移免疫相关性（Vol 69，PG 383,2020）
2. Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients [J] . Battaglia Alessandra, Buzzonetti Alexia, Fossati Marco, Cancer immunology, immunotherapy : . 2020,第3期

机译：在随机相位II中的间接抗体免疫与卵巢癌患者中的Carboplatin / PACLITAXEL PLUS Oragovomab进行随机组合治疗的间接抗体免疫的平移免疫相关性
3. Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer [J] . Blagden Sarah P., Hamilton Anne L., Mileshkin Linda, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第5期

机译：AKT抑制剂Afuresertib与Carboplatin和紫杉醇在复发性铂 - 抗性卵巢癌中的相IB剂量升级和扩展研究
4. A Phase I Study of Fenretinide (LXS) Lym-X-Sorb(TM) Oral Powder in Patients with Recurrent or Resistant Neuroblastoma. [D] . Marachelian, Araz. 2013

机译：Fenretinide（LXS）Lym-X-Sorb（TM）口服粉剂用于复发性或耐药性神经母细胞瘤患者的I期研究。
5. The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent pre-treated ovarian cancer [O] . Michael Eichbaum, Christine Mayer, Regina Eickhoff, 2011

机译：PACOVAR试验：帕唑帕尼（GW786034）和环磷酰胺在铂耐药的复发性预处理卵巢癌患者中的I / II期研究
6. Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients [O] . Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, 2020

机译：校正：转化免疫与卵巢癌患者Carboplatin / PACLITAXEL PLUS OREGOVOMAB在随机相位II中的间接抗体免疫接种在随机抗体免疫研究

302 A phase IB study of indirect immunization with Oregovomab and TLR3 stimulation with hiltonol® (H) in patients with recurrent platinum resistant ovarian cancer (PROC)

著录项

引文网络

相似文献

相关主题

期刊订阅